Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines
Open Access
- 13 September 2012
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 4 (6), 1264-1268
- https://doi.org/10.3892/ol.2012.916
Abstract
Previous studies have demonstrated that pluripotency-associated transcription factors, such as Oct3/4, Nanog and Sox2, play a crucial role in the development and malignant progression of various types of tumors. Breast cancer is the most frequent cancer among females, being a heterogeneous disease, with distinct morphologies, metastatic behavior and therapeutic responses. The expression of Oct3/4, Nanog and Sox2 in 3 human breast cancer cell lines, MCF7, T-47D and MDA-MB-231, was determined. The expression of Oct3/4, Nanog and Sox2 mRNA was determined by reverse transcription polymerase chain reaction (RT-PCR) and protein expression was detected by immunocytohistochemistry. RT-PCR revealed that all three human breast cancer cell lines tested expressed evident Oct3/4, Nanog and Sox-2 mRNA at various levels. Higher levels of Oct3/4 were identified in MCF7 and MDA-MB-231 cells compared with T-47D cells. Higher levels of Nanog were observed in MCF7 and T-47D cells compared with MDA-MB-231 cells and the highest expression of Sox-2 was detected in MCF7 cells. The nuclear localization of Oct3/4, Nanog and Sox-2 was confirmed by immunostaining. Oct3/4, Nanog and Sox2 were expressed in human breast cancer cell lines. Further studies are required to characterize the role of Oct3/4, Nanog and Sox2 in human breast cancer.Keywords
This publication has 41 references indexed in Scilit:
- Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinomaBMC Cancer, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasNature Genetics, 2009
- Overexpression of NANOG in Gestational Trophoblastic Diseases: Effect on Apoptosis, Cell Invasion, and Clinical OutcomeThe American Journal of Pathology, 2008
- Oct-3/4 Expression Reflects Tumor Progression and Regulates Motility of Bladder Cancer CellsCancer Research, 2008
- Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive CellsPLOS ONE, 2008
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumorsNature Genetics, 2008
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Sox2: a possible driver of the basal-like phenotype in sporadic breast cancerLaboratory Investigation, 2007
- Expression of Nanog gene promotes NIH3T3 cell proliferationBiochemical and Biophysical Research Communications, 2005